Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Nan Fang Yi Ke Da Xue Xue Bao ; 43(2): 166-174, 2023 Feb 20.
Article in Chinese | MEDLINE | ID: mdl-36946034

ABSTRACT

OBJECTIVE: To investigate the effects of LASS2/TMSG1 gene overexpression on proliferation and apoptosis of human lung cancer A549 cells and explore the possible mechanism. METHODS: We examined LASS2/TMSG1 expression level in a previously constructed A549 cell line overexpressing LASS2/TMSG1 using Western blotting. The proliferation and apoptosis of the cells were detected using colony-forming assay, CCK-8 assay, Hoechst/PI double staining and flow cytometry. Fourteen nude mice were randomized into 2 groups (n=7) to receive subcutaneous injection of A549 cells with or without LASS2/TMSG1 overexpression on the back of the neck, and the cell proliferation in vivo was observed. The expression levels of p38 MAPK protein and p-p38 MAPK protein in the xenografts were detected with Western blotting. ELISA was used to detect the levels of ceramide and p38 MAPK protein in cultured A549 cell supernatants and the xenografts in nude mice. RESULTS: Compared with the negative control cells, A549 cells with LASS2/TMSG1 overexpression had significantly lowered proliferation ability in vitro with increased early apoptosis rate (P < 0.05), and showed obvious growth inhibition after inoculation in nude mice(P < 0.05). Western blotting showed that in both cultured A549 cells and the xenografts in nude mice, LASS2/TMSG1 gene overexpression significantly increased the expression levels of p38 MAPK protein and p-p38 MAPK protein (P < 0.05); the results of ELISA also revealed significantly increased levels of ceramide and p38 MAPK protein in the cell supernatant andxenografts as well (P < 0.05). CONCLUSION: Overexpression of LASS2/TMSG1 gene can significantly inhibit the proliferation and promote early apoptosis of human lung cancer A549 cells both in vitro and in vivo possibly by upregulating the expressions of ceramide and p38 MAPK protein to activate a signal transduction cascade.


Subject(s)
Lung Neoplasms , p38 Mitogen-Activated Protein Kinases , Animals , Humans , Mice , A549 Cells , Apoptosis , Cell Line, Tumor , Cell Proliferation , Membrane Proteins/metabolism , Mice, Nude , p38 Mitogen-Activated Protein Kinases/metabolism , Signal Transduction , Tumor Suppressor Proteins/genetics , Tumor Suppressor Proteins/metabolism
2.
Int J Antimicrob Agents ; 54(6): 702-708, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31600554

ABSTRACT

OBJECTIVES: Despite extensive clinical use, limited data are available on optimal loading and maintenance doses of vancomycin in critically ill patients. This study aimed to develop a rational approach for optimised dosage of vancomycin given in a continuous infusion in critically ill patients. METHODS: Vancomycin pharmacokinetic (PK) data (total serum concentrations) were obtained from 55 intensive care unit (ICU) patients (Bach Mai Hospital, Hanoi, Vietnam) receiving a 20 mg/kg loading dose followed by continuous infusion stratified by creatinine clearance (CLCr). Population PK modelling and Monte Carlo simulations were performed using a nonlinear mixed-effects modelling (NONMEM) program for a target of 20-30 mg/L to optimise efficacy and minimise nephrotoxicity. RESULTS: A two-compartment model with first-order elimination best fitted the PK data with central and peripheral volumes of distribution of 1.01 and 2.39 L/kg, respectively (allometric scaling to a 70 kg standard subject). The population total clearance of 3.63 L/h was only explained by renal function in the covariate and final model. The simulations showed that a 25-mg/kg loading dose infused over 90 minutes was optimal to reach the target range. The optimal maintenance dose for low renal function (CLCr < 45 mL/min) was 1000-1500 mg/day. For augmented renal clearance (CLCr > 130 mL/min) the dose should be up to 3500 mg/day or even 4500 mg/day to achieve adequate exposure. These simulated maintenance doses were larger than previously proposed for non-ICU patients. CONCLUSION: Large loading and maintenance doses of vancomycin are generally needed in critically ill patients. Because of high interindividual variability in vancomycin PK, drug monitoring may still be necessary.


Subject(s)
Critical Illness , Models, Biological , Vancomycin/administration & dosage , Vancomycin/pharmacokinetics , Adult , Aged , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/pharmacokinetics , Computer Simulation , Dose-Response Relationship, Drug , Drug Administration Schedule , Drug Monitoring , Enterococcus/drug effects , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Monte Carlo Method , Staphylococcus aureus/drug effects
3.
Eur Rev Med Pharmacol Sci ; 22(7): 2000-2004, 2018 04.
Article in English | MEDLINE | ID: mdl-29687855

ABSTRACT

OBJECTIVE: To study the peripheral blood lymphocyte subsets in children with hemophagocytic lymphohistiocytosis (HLH) in acute period as well as remission period, and compare them with healthy children to investigate the significance of lymphocyte subsets in the diagnosis, treatment, and prognosis in children with HLH. PATIENTS AND METHODS: From January 2009 to March 2014, 30 HLH patients were enrolled in this study. Among them, 20 were placed in the remission group, while 10 cases were placed in the death group. 6 cases died within 8 weeks due to the illness, and 4 cases died within 9 to 34 weeks. 30 children who were confirmed healthy after physical check-ups in the same period were enrolled in the control group. Peripheral blood was collected from both groups and lymphocyte subsets were studied using flow cytometry. RESULTS: The ratios of CD3+ T and CD8+ T cells increased in the HLH remission group and the death group, while CD4+, CD4+/CD8+ and CD3-CD16+CD56+NK ratios decreased. Difference detected in the proportion of CD19+ B cells was not statistically significant. By comparing lymphocyte subsets in the HLH acute period and the remission period in HLH patients we discovered that the differences in CD3+, CD8+, CD4+ and CD4+/CD8+, CD19+ B cells ratios were not statistically significant (p > 0.05). CD3-CD16+CD56+NK cells ratios in the remission period increased significantly. CONCLUSIONS: The lymphocyte subsets in children with HLH underwent obvious changes and there was an imbalance in cellular immunity. We believe that dynamic detection of changes may help us to evaluate the prognosis and the effect of the treatment.


Subject(s)
Lymphocyte Subsets/immunology , Lymphohistiocytosis, Hemophagocytic/immunology , Child , Child, Preschool , Female , Humans , Infant , Male , Prognosis
4.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi ; 29(4): 523-525, 2017 Jun 09.
Article in Chinese | MEDLINE | ID: mdl-29508599

ABSTRACT

Objective To investigate the capabilities of Plasmodium microscopic examinations of professional staff in medical institutions in Wuxi City, so as to provide evidences for improving malaria control and elimination work in the future. Methods The data of questionnaires for laboratorial staff in charge of Plasmodium microscopic examinations were collected and analyzed in the medical institutions in Wuxi City in 2016, and the influencing factors related to the capabilities of Plasmodium microscopic examinations were analyzed by the method of logistic regression. Results Totally 54 laboratorial workers in 54 medical institutions in Wuxi City were investigated, 16 of them were male, and 38 were female, and the ratio of male to female was 0.42:1. Among the 54 laboratorial workers, 12 persons (22.22%) had the experience of detecting Plasmodium in the work. The multivariable analysis showed the ability to detect Plasmodium was associated with male laboratorial workers (adjusted OR = 0.11, 95%CI:0.02-0.53), laboratorial workers with intermediate or higher professional titles (adjusted OR = 5.31, 95%CI: 1.04-27.19) and laboratorial workers from county and township medical institutions (adjusted OR = 0.04, 95%CI:0.01-0.98). Conclusions All of the medical institutions in Wuxi City have the capability of microscopic examinations of Plasmodium. However, the ability of laboratorial staff in primary hospitals still should be improved.


Subject(s)
Laboratory Personnel/standards , Microscopy , Plasmodium/isolation & purification , Professional Competence , Cities , Female , Humans , Malaria , Male
5.
Genet Mol Res ; 13(1): 1491-6, 2014 Mar 06.
Article in English | MEDLINE | ID: mdl-24446343

ABSTRACT

Previous studies focusing on the association of PTGS2 polymorphism -765G>C with coronary artery disease (CAD) have failed to reach the same conclusion. In the present study, we performed a meta-analysis to systematically summarize the possible association between PTGS2 polymorphism -765G>C and the risk of CAD. We conducted a search of case-control studies on the associations of PTGS2 with susceptibility to CAD in PubMed, EMBASE, and Chinese National Knowledge Infrastructure databases. Data from eligible studies were extracted for meta-analysis. CAD risk associated with PTGS2 -765G>C was estimated by pooled odds ratios (ORs) and 95% confidence intervals (95%CI) with the RevMan 5.2 software. Eleven independent case-control studies on PTGS2 -765G>C were included in our meta-analysis. Our results showed that PTGS2 -765G>C was associated with a decreased risk of CAD (OR = 0.66, 95%CI = 0.56-0.79; P < 0.001). This meta-analysis suggests that PTGS2 -765G>C is associated with a decreased risk of CAD.


Subject(s)
Coronary Artery Disease/genetics , Cyclooxygenase 2/genetics , Genetic Predisposition to Disease , Polymorphism, Genetic , Alleles , Case-Control Studies , Genetic Association Studies , Genotype , Humans , Odds Ratio , Publication Bias
6.
J Chem Phys ; 140(4): 041106, 2014 Jan 28.
Article in English | MEDLINE | ID: mdl-25669497

ABSTRACT

Three spin-orbit states, 1(2)Π1/2, 2(2)Π3/2, and 2(2)Π1/2, of chloroiodine anion (ICl(-)) formed by low-energy electron attachment in the Franck-Condon region are associated with the dissociative limits of I(-) ((1)S0) and Cl ((2)P3/2) or Cl(*) ((2)P1/2) fragments. Within the adiabatic scheme, the presumptive Π-symmetry of the fragment angular distributions is dramatically changed to be the Π-Σ mixing symmetry, due to the significant spin-orbit interaction effect on the electronic state couplings of ICl(-). The present experimental approach also enables us to separate the contributions of different electronic states from the mixed states, providing a crucial method for quantitatively evaluating the configuration-interaction wavefunctions.

7.
Oncogene ; 33(24): 3205-16, 2014 Jun 12.
Article in English | MEDLINE | ID: mdl-23851505

ABSTRACT

The transcription factor GATA3 is a key regulator of mammary gland development and a definitive marker of luminal breast cancer. However, the molecular mechanisms underlying the role of GATA3 in breast carcinogenesis is still not fully understood. We report here that GATA3 promotes cell proliferation and tumorigenesis by facilitating the G1/S transition through its transcription regulation of the CCND1 gene in breast cancer cells. We found that GATA3 is physically associated with poly-ADP ribose polymerase-1 (PARP1), an enzyme modifying nuclear proteins by poly(ADP-ribosyl)ation. We showed that PARP1 acts as a transcription coactivator for GATA3 in breast cancer cells and demonstrated that GATA3 cooperates with PARP1 in transactivation of the CCND1 gene. We demonstrated that PARP1 competes with linker histone H1 to maintain a transcriptional competent chromatin environment for CCND1 gene. Our results unveiled a molecular basis for the coordinated regulation between GATA3 and PARP1 in transcription activation, providing a mechanism for GATA3 in breast carcinogenesis.


Subject(s)
Breast Neoplasms/genetics , Breast Neoplasms/pathology , Cyclin D1/genetics , GATA3 Transcription Factor/metabolism , Gene Expression Regulation, Neoplastic , Histones/metabolism , Poly(ADP-ribose) Polymerases/metabolism , Animals , Apoptosis , Base Sequence , Blotting, Western , Breast Neoplasms/metabolism , Cell Cycle , Cell Movement , Cell Proliferation , Cell Transformation, Neoplastic/pathology , Chromatin Immunoprecipitation , Cyclin D1/metabolism , Female , Flow Cytometry , GATA3 Transcription Factor/genetics , Humans , Immunoprecipitation , Mice , Mice, Inbred BALB C , Mice, Nude , Molecular Sequence Data , Peptide Fragments , Poly (ADP-Ribose) Polymerase-1 , Poly(ADP-ribose) Polymerases/genetics , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Nucleic Acid , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Transcription, Genetic , Tumor Cells, Cultured , Tumor Stem Cell Assay , Xenograft Model Antitumor Assays
8.
Eur Rev Med Pharmacol Sci ; 17(19): 2644-53, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24142613

ABSTRACT

AIM: The objective of this study is to examine effects of extracts from cooked lentils on angiotensin II (Ang II)-induced hypertension, cardiac hypertrophy and fibrosis in normotensive rats. MATERIALS AND METHODS: Animals were divided into four groups (n=5 each group): control group, Ang II group, Ang II plus cooked lentil extract (Ang II+CLE) group, and Ang II plus raw lentil extract (Ang II+RLE) group. The telemetry blood pressure transducers were implanted into all rats. A telemetry BP probe was positioned intra-abdominally and secured to the ventral abdominal muscle with the catheter inserted into the lower abdominal aorta. Heart wall thickness, cross-sectional area of cardiomyocytes, diameter of the arterial cross-sections, and perivascular fibrosis in heart and kidney were measured. The surface area of positive-staining cardiomyocytes was analyzed using image analysis software. Reactive oxygen species (ROS) generation was determined using an oxidant-sensitive fluorogenic probe. RESULTS: Rats that received cooked or raw lentil extracts (oral administration, 8 weeks) show significantly attenuated Ang II-induced elevation in blood pressure, cardiac hypertrophy, perivascular fibrosis. Results demonstrated that pretreatment of cardiomyocytes with cooked or raw lentil extract significantly attenuated the Ang II-induced increase in the size of cells (16.0±1.7% and 21.2±2.9%, respectively, n=5, p < 0.05), and cooked or raw lentil extracts also attenuated the Ang II-induced increase in the reactive oxygen species levels in cardiomyocytes (19.8±2.2% & 26.6±3.1%, respectively, n=5, p < 0.05). CONCLUSIONS: This study showed that extracts from cooked lentils could prevent Ang II-induced elevation in blood pressure, cardiac hypertrophy, small arterial remodeling and perivascular fibrosis, and heating process does not have any significant affect on these protective effects.


Subject(s)
Angiotensin II/pharmacology , Cardiomegaly/drug therapy , Hypertension/drug therapy , Lens Plant , Plant Extracts/therapeutic use , Animals , Male , Myocytes, Cardiac/metabolism , Oxidative Stress/drug effects , Phytotherapy , Rats , Rats, Sprague-Dawley , Ventricular Remodeling/drug effects
9.
Eur J Cancer Care (Engl) ; 22(5): 617-25, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23731124

ABSTRACT

Although a number of genetic studies have attempted to link the multidrug resistance (MDR1) C3435T polymorphism to risk of leukaemia, the results were often inconsistent. The present study aimed at investigating the pooled association using a meta-analysis on the published studies. 1933 cases and 2215 controls of 11 published studies in English before June 2012 were involved in the updated meta-analysis. Furthermore, subgroup analysis was performed in different ethnic and leukaemia subtype groups. This meta-analysis suggests that the MDR1 C3435T polymorphism associate with risk of leukaemia. The effect of the variant on the expression levels and the possible functional role of the variant in leukaemia should be addressed in further studies.


Subject(s)
ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics , Leukemia/genetics , Polymorphism, Genetic/genetics , Case-Control Studies , Gene Frequency/genetics , Genetic Predisposition to Disease/genetics , Humans , Risk Factors
10.
Naunyn Schmiedebergs Arch Pharmacol ; 386(3): 205-15, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23263451

ABSTRACT

Myocardial ischemia affects mitochondrial function leading to ionic imbalance and susceptibility to ventricular fibrillation. Trimetazidine (TMZ), a metabolic agent, is clinically used as an anti-anginal therapy. This study was conducted to compare the effect of TMZ 20 mg immediate release (IR) and TMZ 35 mg modified release (MR), two bioequivalent marketed formulations of TMZ, on cardioprotection during acute ischemia in pigs. A 4-day oral treatment with TMZ 20 mg IR (800 mg, tid) or TMZ 35 mg MR (1,400 mg, bid) had no effect on ventricular fibrillation threshold (VFT) prior to ischemia but significantly prevented the decrease in VFT observed in placebo-treated groups after a 1-min left anterior descending coronary artery occlusion. This effect occurred without modifying cardiac hemodynamic and conduction parameters. In both TMZ-treated groups, a significant reduction of the ischemic area as well as a protection of cardiomyocytes were observed. Cardiac enzymatic activity (phosphorylase, succinate dehydrogenase, ATPase) was increased in TMZ-treated groups. Both formulations preserved mitochondrial structure and improved mitochondrial function as demonstrated by a twofold increase of oxidative phosphorylation, by a reduction of reactive oxygen species (ROS) production (>30 %) and by a trend to increase the mitochondrial calcium retention capacity. In this model of ischemia, both TMZ formulations, leading to equivalent TMZ plasma exposures, demonstrated similar cardioprotective effects. This protection could be attributed to a preservation of mitochondrial structure and function, which plays a central role in ATP and ROS production and consequently could be considered as a target of cardioprotection.


Subject(s)
Acute Coronary Syndrome/drug therapy , Cardiotonic Agents/therapeutic use , Mitochondria, Heart/drug effects , Trimetazidine/therapeutic use , Ventricular Fibrillation/prevention & control , Action Potentials/drug effects , Acute Coronary Syndrome/complications , Acute Coronary Syndrome/pathology , Acute Coronary Syndrome/physiopathology , Animals , Cardiotonic Agents/administration & dosage , Delayed-Action Preparations , Disease Models, Animal , Drug Administration Schedule , Heart Rate/drug effects , Mitochondria, Heart/enzymology , Mitochondria, Heart/pathology , Reactive Oxygen Species/metabolism , Swine , Trimetazidine/administration & dosage , Ventricular Fibrillation/etiology , Ventricular Fibrillation/pathology , Ventricular Fibrillation/physiopathology
11.
Oncogene ; 32(32): 3711-21, 2013 Aug 08.
Article in English | MEDLINE | ID: mdl-22926524

ABSTRACT

The p53 tumor suppressor is important in many aspects of cell biology. Tight regulation of p53 is thus imperative for maintaining cell homeostasis and preventing tumorigenesis. The stabilization and activity of p53 is primarily regulated by MDM2, which is encoded for by HDM2. However, how the expression and activity of MDM2 is regulated remains largely unknown. Here, we report a novel BTB and BEN domains-containing protein, RBB. We demonstrated that RBB is a novel transcriptional repressor binding specific DNA motif via a homodimer and interacting with the nucleosome remodeling and deacetylase (NuRD) complex. Genome wide transcription target analysis by ChIP sequencing revealed that RBB represses the transcription of a series of functionally important genes including HDM2. We showed that RBB recruits the NuRD complex to the internal promoter of HDM2 and inhibits the expression of MDM2 protein, leading to subsequent stabilization of tumor suppressor p53. Significantly, we showed that RBB suppresses cell proliferation and sensitizes cells to DNA damage-induced apoptosis. Our data indicate that RBB is a novel transcriptional repressor and an important regulator of p53 pathway.


Subject(s)
Oncogenes , Proto-Oncogene Proteins c-mdm2/genetics , Tumor Suppressor Proteins/physiology , Acetylation , Animals , Apoptosis , Cell Line, Tumor , Chromatin/chemistry , Cloning, Molecular , DNA/metabolism , DNA Damage , Female , Histones/metabolism , Humans , Mi-2 Nucleosome Remodeling and Deacetylase Complex/metabolism , Mice , Promoter Regions, Genetic , Protein Multimerization , Tumor Suppressor Protein p53/physiology
12.
Hum Exp Toxicol ; 25(6): 305-9, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16866187

ABSTRACT

Cardiotoxicity is a rare, but well-recognized complication of treatments with the anti-cancer drug 5-fluorouracil (5FU). The underlying mechanism, however, is not fully elucidated. A spasm of the coronary arteries is often considered to be the leading cause of myocardial ischemia and decreased contractility associated with 5FU. As spasm cannot account for all reported adverse cardiac effects, the present study was undertaken to search for alternative mechanisms. Groups of six rabbits were given either a single intravenous dose of 50 mg/kg 5FU or four intravenous doses of 15 mg/kg 5FU at 7-day intervals. A third group served as control. The heart was removed shortly after death or scheduled sacrifice of the animals, to perform macroscopic and microscopic examinations of the heart and to evidence apoptosis by the TUNEL method. Following a single dose of 50 mg/kg 5FU, all animals rapidly developed a massive hemorrhagic myocardial infarct with spasms of the proximal coronary arteries. Repeated infusions of 15 mg/kg 5FU induced left ventricular hypertrophy, foci of myocardial necrosis, thickening of intra-myocardial arterioles, and disseminated apoptosis in myocardial cells of the epicardium, as well as endothelial cells of the distal coronary arteries. These results indicate that a spasm of the coronary arteries is not the only mechanism of 5FU cardiotoxicity, and that apoptosis of myocardial and endothelial cells can result in inflammatory lesions mimicking toxic myocarditis.


Subject(s)
Antimetabolites, Antineoplastic/toxicity , Cardiomyopathies/chemically induced , Coronary Disease/chemically induced , Fluorouracil/therapeutic use , Animals , Apoptosis/drug effects , Cardiomyopathies/pathology , Coronary Disease/pathology , Electrocardiography , Female , Male , Rabbits
14.
Arch Virol ; 150(8): 1677-84, 2005 Aug.
Article in English | MEDLINE | ID: mdl-15834655

ABSTRACT

Little is known about assembly of non-primate foamy virus (FV) such as bovine foamy virus (BFV). To help determine the requirements for assembly of BFV, we constructed BFV-Gag expression plasmids containing all or part of the gag gene, with or without modification by addition of myristate (Myr). Each construct was transfected alone, and with pFenv, into Sf-9 insect cells. The results showed that only the entire Gag could transit through nucleus, which is required for BFV viral assembly in the cytoplasm. Unlike other retroviruses (but like primate foamy viruses), BFV requires the coexpression of the Env protein for viral particle budding. In the case of BFV, this occurs at the plasma membrane rather than the endoplasmic reticulum (ER), due to lack of a functional ER retrieval signal (ERRS). The results also showed that addition of a Myr-membrane targeting signal to the C-terminus of Gag could restore the budding from plasma membrane, implying that Myr-membrane targeting signal could substitute for Env protein in budding.


Subject(s)
Capsid/metabolism , Spumavirus/physiology , Animals , Biological Transport , Cell Line , Cell Membrane/metabolism , Cell Nucleus/metabolism , Gene Products, gag/metabolism , Spumavirus/isolation & purification , Viral Envelope Proteins/metabolism , Virus Assembly
16.
Rev Med Interne ; 24(9): 577-84, 2003 Sep.
Article in French | MEDLINE | ID: mdl-12951178

ABSTRACT

PURPOSE: Review of the literature on adult Kawasaki disease. CURRENT KNOWLEDGE AND KEY POINTS: Kawasaki disease is an acute multisystemic vasculitis affecting predominantly young children. Several studies have suggested that Kawasaki disease is mediated by bacterial superantigens. The diagnosis is established on clinical criteria since no specific laboratory test yet exists for this disorder. The severity of Kawasaki disease relates to the possible occurrence of coronary aneurysms in 20% of childhood cases. Treatment with intravenous immunoglobulins before day 10 is recommended to prevent aneurysm formation. The occurrence of Kawasaki disease is unusual in adults and 52 cases only have been reported in adult patients. Seventy-one per cent of cases occur between 18 and 30 years. The incidence of specific clinical features is quite similar between adults and children. However meningitis and thrombocytosis are more common in children than in adults, while conversely both arthralgias and liver function abnormalities are more common among adults. Coronary aneurysms are less common in the adults with Kawasaki disease. Other diseases with similar clinical presentation such as drug hypersensitivity reaction and the toxic shock syndrome must be ruled out. Kawasaki disease is often diagnosed after the acute phase at the step of desquamation, when it is too late to expect any beneficial effect from immunoglobulins. FUTURE PROSPECTS AND PROJECTS: Diagnostic criteria of Kawasaki disease have not been validated in an adult population. Criteria of exclusion are necessary to eliminate toxic shock syndrome and drug hypersensitivity syndrome. An international retrospective study to collect data on epidemiologic, clinical, laboratory, and cardiovascular features of adult Kawasaki disease is necessary to validate specific diagnostic criteria and to improve the knowledge on this disease.


Subject(s)
Mucocutaneous Lymph Node Syndrome/complications , Mucocutaneous Lymph Node Syndrome/diagnosis , Adolescent , Adult , Age of Onset , Aged , Diagnosis, Differential , Drug Hypersensitivity/etiology , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Male , Middle Aged , Mucocutaneous Lymph Node Syndrome/pathology , Prognosis , Shock, Septic/etiology
17.
Biomaterials ; 19(7-9): 771-6, 1998.
Article in English | MEDLINE | ID: mdl-9663752

ABSTRACT

Titanium oxide films were synthesized on titanium, cobalt alloy and low-temperature isotropic pryolytic carbon by ion beam enhanced deposition. The non-stoichiometrical titanium oxide films were obtained. Blood compatibility of the films were evaluated by clotting time measurement, platelet adhesion investigation and hemolysis analyses. The results revealed that blood compatibility of the materials was improved by the coating of titanium oxide films. Semiconductor nature of non-stoichiometric titanium oxide films might be responsible for the improvement of blood compatibility.


Subject(s)
Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Platelet Adhesiveness/drug effects , Titanium/blood , Titanium/chemistry , Animals , Blood Coagulation/drug effects , Hemolysis/drug effects , Rabbits , Titanium/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...